BioImagene, Inc. Announces Appointment of ForteBio CEO - Dr. Joseph D. Keegan to Its Board of Directors

CUPERTINO, Calif.--(BUSINESS WIRE)--BioImagene, a leading provider of innovative imaging software and systems for cancer diagnosis and research is pleased to announce Dr. Joseph Keegan’s appointment as a director to the company’s board.